Nano Flow™ off-the-shelf gold conjugates are designed to help diagnostic developers accelerate assay development and improve test performance. By providing ready-to-use conjugates, we remove the need for weeks of optimization required to master in-house conjugation. In many cases, off-the-shelf conjugates can even deliver higher sensitivity than directly conjugated antibodies, enabling faster progress and more reliable results.

Why choose Nano Flow off-the-shelf conjugates?

Accelerated development

Save several weeks by bypassing the conjugation optimization step.

Improved sensitivity

In specific assays, off-the-shelf conjugates outperform direct antibody conjugates.

Reproducibility

Strict lot-to-lot quality controls ensure consistent performance.

Flexibility

Two complementary portfolios adapted to multiple diagnostic applications.

Our off-the-shelf conjugate families

Primary vs Secondary conjugates – what’s the difference?

Primary conjugates Secondary conjugates
Antibody conjugates that bind directly to the target analyte (e.g., CRP, Troponin, Influenza, SARS-CoV-2). Antibody or protein conjugates that bind to another antibody (e.g., anti-human IgG, anti-mouse IgG, Streptavidin, Protein A/G).
Used both in assay development/prototyping and in the final diagnostic assay as the detection reagent. Used both for assay development (universal detection tools) and in final diagnostic products where secondary detection is the preferred format.
Application-specific, tailored to infectious diseases, cardiac, inflammation, antimicrobial resistance, etc. Flexible reagents with broad applicability across research, prototyping, and commercial LFA manufacturing.

Whether you need universal secondary conjugates or disease-specific primary conjugates, Nano Flow provides ready-to-use solutions that help you reach the market faster with reliable and high-performance assays.